-
43 Posts
-
1 Photos
-
0 Videos
-
employee at Shirley, NY, USA
-
Studied Engineering at Shirley, NY, USAClass of Shirley, NY, USA
-
16/10/2000
-
Followed by 4 people
Recent Updates
-
Beyond the Carpet Bombing: The Rise of the Biological "Trojan Horse"For decades, the biggest challenge in medicine wasn't just finding a drug that worked—it was getting that drug to the right "address" without destroying everything else along the way. Traditional chemotherapy, for instance, is often compared to carpet bombing: it kills the enemy, but it also devastates the surrounding city. As we move through 2026, a quiet revolution in Targeted...0 Comments 0 Shares 44 Views 0 ReviewsPlease log in to like, share and comment!
-
Tracing the Path of Antibody Innovation through Advanced B-Cell Isolation TechniquesIn modern therapeutic antibody development, the ability to isolate naturally paired heavy and light chain antibody sequences from B cells is a decisive factor in generating fully human, high-affinity monoclonal antibodies (mAbs). Researchers now rely on innovative B-cell sorting workflows that combine precision, efficiency, and biological relevance. Among the most widely used strategies are...0 Comments 0 Shares 54 Views 0 Reviews
-
Advanced Isobaric Amino Acid Discrimination Enhancing De Novo Protein SequencingIn the rapidly evolving field of protein and antibody analysis, achieving exceptional sequence precision is more important than ever. With advances in mass spectrometry and data analytics, the realm of de novo sequencing has experienced pivotal breakthroughs—especially when it comes to the challenge of distinguishing so-called "ambiguous" amino acids. Today we'll explore how...0 Comments 0 Shares 57 Views 0 Reviews
-
From Infection to Innovation: How Oncolytic Viruses Empower the Immune System to Fight CancerIn the rapidly evolving landscape of cancer immunotherapy, oncolytic virotherapy has emerged as a dynamic force capable of amplifying the immune response against tumors. Once seen merely as a means of direct tumor lysis, oncolytic viruses (OVs) are now recognized for their ability to reshape the tumor microenvironment, recruit immune cells, and enhance the effectiveness of existing therapeutic...0 Comments 0 Shares 54 Views 0 Reviews
-
Redesigning the Rules of Drug Discovery Through Protein DegradationThe rise of targeted protein degradation (TPD) has opened a new chapter in modern drug discovery. Unlike traditional inhibitors that merely block protein activity, degraders work by eliminating disease-causing proteins altogether through the ubiquitin–proteasome system. Behind this elegant mechanism lies a delicate balance between three essential components — linkers, ligands, and...0 Comments 0 Shares 62 Views 0 Reviews
-
The Quiet Revolution: How AI-Driven Antibody Engineering Is Rewriting Biotherapeutic DiscoveryThe biopharmaceutical industry is going through a silent but profound transformation. While headlines tend to focus on blockbuster drugs or billion-dollar mergers, another movement is gathering momentum beneath the surface—one powered not by laboratory throughput alone, but by algorithmic intelligence. Antibody engineering, once defined by trial-and-error approaches and lengthy...0 Comments 0 Shares 2K Views 0 Reviews
-
Why Ex Vivo Gastrointestinal Models Are Redefining Human-Relevant ResearchA new kind of gold rush is quietly reshaping drug discovery—and this time, the treasure is not buried in animal facilities or clinical trial databases, but preserved in living human gastrointestinal tissue. As pharmaceutical pipelines accelerate and regulatory expectations tighten, traditional in vivo models are showing their limits. Animal studies remain costly,...0 Comments 0 Shares 2K Views 0 Reviews
-
From Inflammation to Innovation: The Impact of RA and Asthma Models on Drug DevelopmentThe pharmaceutical landscape is entering a phase of unprecedented focus on immune-mediated diseases, with research teams racing to develop treatments for conditions ranging from autoimmune disorders to chronic inflammatory diseases. The key to this progress is not just advanced molecular tools—it is also the strategic use of robust preclinical disease models that faithfully recapitulate...0 Comments 0 Shares 2K Views 0 Reviews
-
The Rising Demand for High-Potency ADC Payloads: Why the Supply Chain Is Being Reshaped in 2025Antibody–drug conjugates (ADCs) continue to reshape the oncology pipeline, driven by the pursuit of payloads that can deliver stronger potency, improved tumor selectivity, and reduced systemic toxicity. Although more than a decade has passed since the approval of the first ADC, payload development remains one of the fastest-moving components of the field. With growing interest in high-DAR...0 Comments 0 Shares 1K Views 0 Reviews
-
Riding the Non-IgG Wave: Why Researchers Are Turning to Alternative ImmunoglobulinsFor years, the life sciences community has focused its attention—and budgets—on IgG antibodies. They were the gold standard for therapeutic development, biomarker screening, and diagnostic innovation. But as biological questions grow more complex and precision medicine becomes increasingly nuanced, a new trend has emerged: a surge of interest in non-IgG antibodies and proteins....0 Comments 0 Shares 1K Views 0 Reviews
-
https://ubuntusafa.com/blogs/417041/How-Scientists-Are-Reinventing-Vaccines-Through-Lipid-Carriers-and-RNAIn the rapidly evolving field of antibody therapeutics, bispecific antibodies (BsAbs) are gaining momentum thanks to their ability to engage two distinct targets simultaneously. One critical application lies in developing molecules that specifically interfere with receptor-mediated signalling. For example, when a BsAb is engineered for bispecific receptor binding, it can simultaneously target...0 Comments 0 Shares 549 Views 0 Reviews
-
How Monkey Models Are Shaping the Future of Translational MedicineTranslational research depends on reliable animal models that can accurately mimic human biology. Among all preclinical options, non-human primates (NHPs) stand out for their close genetic, immunological, and physiological similarity to humans. Two key NHP species—the Cynomolgus Monkey and the Marmoset—have become indispensable in bridging the gap between discovery and clinical...0 Comments 0 Shares 501 Views 0 Reviews
-
Turning Digital RNA Blueprints into Real Therapeutics through Polyplex InnovationWhen the first mRNA vaccines made global headlines, they didn't just signal a medical milestone—they sparked a revolution. Scientists suddenly realized that mRNA wasn't only a fleeting molecule of genetic code but a programmable platform capable of driving the future of gene therapy. Yet, unlocking its full potential requires a delicate balance of design precision and delivery...0 Comments 0 Shares 547 Views 0 Reviews
-
How Scientists Are Reinventing Vaccines Through Lipid Carriers and RNA AdjuvantsIn recent years, vaccine science has evolved far beyond traditional formulations. Instead of relying solely on inactivated or attenuated pathogens, modern researchers are now engineering delivery vehicles and adjuvants that can fine-tune immune responses with precision. This combination of smart delivery systems and optimized immune stimulants represents a major leap toward safer, more...0 Comments 0 Shares 613 Views 0 Reviews
-
Optimizing Plasmid CDMO Solutions for Faster Gene Therapy DevelopmentIn the rapidly evolving field of gene therapy, high-quality plasmids play a crucial role as the backbone of genetic constructs. Efficient production of these plasmids is essential for preclinical research, clinical trials, and large-scale therapeutic applications. This is where contract development and manufacturing organization (CDMO) services for plasmids come into play, offering end-to-end...0 Comments 0 Shares 605 Views 0 Reviews
-
When 3D Models Enter the Lab: A New Chapter in Drug Discovery BeginsThe transition from traditional two-dimensional (2D) cultures to three-dimensional (3D) systems represents one of the most transformative shifts in contemporary drug discovery. In recent years, 3D technologies have begun to close the long-standing gap between preclinical models and human biology—providing more physiologically relevant systems for compound evaluation, efficacy prediction,...0 Comments 0 Shares 631 Views 0 Reviews
-
Microencapsulation Strategies for Enhancing Probiotic Viability and FunctionProbiotics are widely celebrated for their health benefits—from maintaining gut microbiota balance to modulating the immune system and even influencing the gut–brain axis. Yet, ensuring that live probiotics survive the harsh journey through the gastrointestinal (GI) tract and reach their site of action remains one of the biggest hurdles in the field. Along the way, stomach...0 Comments 0 Shares 714 Views 0 Reviews
-
Centella asiatica-Derived Exosomes: Natural Nanocarriers for Skin Repair and Anti-AgingCentella asiatica, also known as Gotu Kola, has long been prized in traditional medicine for its wound-healing, skin-rejuvenating, and anti-inflammatory properties. Modern biotechnology now suggests that its therapeutic potential extends far beyond its well-known triterpenoids and saponins. Recent research has uncovered a new class of bioactive entities within this herb—plant-derived...0 Comments 0 Shares 630 Views 0 Reviews
-
Bridging Inflammation and Immunotherapy: Lessons from IL-6, BCL2, and NK CellsCancer is far more than uncontrolled cell growth. Its development is shaped by a complex dialogue between tumor cells, their surrounding microenvironment, and the body’s immune system. Among the many players in this process, three stand out: Interleukin-6 (IL-6), B-cell lymphoma 2 (BCL2), and natural killer (NK) cells. Each exerts powerful yet interconnected influences on tumor...0 Comments 0 Shares 821 Views 0 Reviews
-
The New Age of Antiviral Immunity: What NK Cells Teach Us About Rapid ResponseThroughout human history, the immune system has stood as our most powerful shield against viral threats. Among its many components, Natural Killer (NK) cells have emerged as a pivotal force in antiviral defense, thanks to their remarkable ability to identify and eliminate infected cells without prior sensitization. From COVID-19 to influenza and HIV, NK cells are now recognized as key players...0 Comments 0 Shares 819 Views 0 Reviews
More Stories
Sponsored